Effects and side-effects of partial ileal by-pass surgery for familial hypercholesterolaemia

Gut
|July 1, 1982
PubMed

Insights

Partial ileal bypass surgery significantly lowers cholesterol in familial hypercholesterolaemia patients. However, it causes metabolic side effects like diarrhoea and reduced calcium absorption, requiring ongoing medical supervision.

Area of Science:

  • Cardiovascular Medicine
  • Gastroenterology
  • Metabolic Disorders

Background:

  • Familial hypercholesterolaemia is a genetic disorder leading to high cholesterol levels.
  • Effective long-term management strategies for familial hypercholesterolaemia are crucial.

Purpose of the Study:

  • To evaluate the efficacy and safety of partial ileal bypass surgery in patients with familial hypercholesterolaemia.
  • To assess the long-term metabolic consequences of this surgical intervention.

Main Methods:

  • A cohort of ten patients with familial hypercholesterolaemia underwent partial ileal bypass surgery.
  • Plasma lipid profiles, liver enzymes, and gastrointestinal symptoms were monitored over 18 months.

Main Results:

  • Significant reductions in plasma cholesterol (41-38%) and low-density lipoprotein cholesterol (51-46%) were observed at 6 and 18 months.
  • High-density lipoprotein cholesterol, very low-density lipoprotein cholesterol, and triglycerides remained unaffected.
  • Transient increases in alanine aminotransferase and persistent gastrointestinal issues (diarrhoea, steatorrhoea) were noted.
  • Long-term side effects included increased urinary oxalate excretion and decreased calcium absorption.

Conclusions:

  • Partial ileal bypass surgery is effective in reducing cholesterol levels for familial hypercholesterolaemia.
  • The procedure is associated with notable metabolic side effects, including gastrointestinal disturbances and altered mineral absorption.
  • Patients require continuous medical monitoring due to potential long-term complications.

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Cholecystitis01:20

Cholecystitis

Cholecystitis is inflammation of the gallbladder, most commonly caused by obstruction of the cystic duct. This blockage prevents bile from draining, leading to gallbladder distension, inflammation, and potentially serious complications. This condition may present acutely or chronically and can happen with or without gallstones.EtiologyAbout 95% of cholecystitis cases are calculous, caused by gallstones blocking the cystic duct, leading to bile accumulation and inflammation of the gallbladder...